Inhibitor Therapeutics, Inc.
itraconazole
Basal Cell Carcinoma Nevus Syndrome (BCCNS)
Resolved
74days ago
Phase 2 readout · Apr 24, 2026
What's at stake
Phase 2 trial results for itraconazole in Basal Cell Carcinoma Nevus Syndrome (BCCNS) are due Apr 24, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 15h ago
“Period 3 scheduled for April 24, 2026.”